{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:13:06Z","timestamp":1759331586819,"version":"build-2065373602"},"reference-count":17,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,17]],"date-time":"2021-08-17T00:00:00Z","timestamp":1629158400000},"content-version":"am","delay-in-days":350,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.jfo.2019.11.011","type":"journal-article","created":{"date-parts":[[2020,7,3]],"date-time":"2020-07-03T20:52:38Z","timestamp":1593809558000},"page":"598-603","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparaison clinico-\u00e9pid\u00e9miologique des pathologies du spectre des neuromy\u00e9lites optiques"],"prefix":"10.1016","volume":"43","author":[{"given":"D.","family":"Osswald","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"De Seze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Collongues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Speeg-Schatz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfo.2019.11.011_bib0090","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","article-title":"The spectrum of neuromyelitis optica","volume":"6","author":"Wingerchuk","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jfo.2019.11.011_bib0095","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1084\/jem.20050304","article-title":"IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4\u00a0water channel","volume":"202","author":"Lennon","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.jfo.2019.11.011_bib0100","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis","volume":"364","author":"Lennon","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jfo.2019.11.011_bib0105","doi-asserted-by":"crossref","first-page":"529","DOI":"10.3389\/fimmu.2017.00529","article-title":"Myelin Oligodendrocyte Glycoprotein: Deciphering a Target in Inflammatory Demyelinating Diseases","volume":"8","author":"Peschl","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.jfo.2019.11.011_bib0110","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.neurol.2016.03.003","article-title":"Neuromyelitis optica spectrum disorder (NMOSD): a new concept","volume":"172","author":"De S\u00e8ze","year":"2016","journal-title":"Rev Neurol"},{"key":"10.1016\/j.jfo.2019.11.011_bib0115","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.jfo.2019.11.011_bib0120","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1177\/1352458508091367","article-title":"Tracking retinal nerve fiber layer loss after optic neuritis: a prospective study using optical coherence tomography","volume":"14","author":"Costello","year":"2008","journal-title":"Mult Scler"},{"key":"10.1016\/j.jfo.2019.11.011_bib0125","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.neurol.2018.02.084","article-title":"Neuromyelitis optica spectrum disorders: Features of aquaporin-4, myelin oligodendrocyte glycoprotein and double-seronegative-mediated subtypes","volume":"174","author":"Alves Do Rego","year":"2018","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/j.jfo.2019.11.011_bib0130","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1007\/s00415-015-7844-y","article-title":"Features of anti-aquaporin 4\u00a0antibody-seropositive Chinese patients with neuromyelitis optica spectrum optic neuritis","volume":"262","author":"Li","year":"2015","journal-title":"J Neurol"},{"key":"10.1016\/j.jfo.2019.11.011_bib0135","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1590\/0004-282X20140097","article-title":"Sj\u00f6gren syndrome and neuromyelitis optica spectrum disorder co-exist in a common autoimmune milieu","volume":"72","author":"Carvalho","year":"2014","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1016\/j.jfo.2019.11.011_bib0140","unstructured":"Le syndrome de Gougerot Sj\u00f6gren. F\u00e9d\u00e9ration des maladies dysimmunitaires, CHU de N\u00eemes, http:\/\/www.chu-nimes.fr\/federation_maladies_dysimmunitaires\/patients-le-syndrome-de-gougerot-sjogren.html."},{"key":"10.1016\/j.jfo.2019.11.011_bib0145","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0022-510X(02)00043-6","article-title":"Devic's neuromyelitis optica: clinical, laboratory, MRI and outcome profile","volume":"197","author":"De Seze","year":"2002","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jfo.2019.11.011_bib0150","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1212\/WNL.0000000000000101","article-title":"Distinction between MOG antibody-positive and AQP4\u00a0antibody-positive NMO spectrum disorders","volume":"82","author":"Sato","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.jfo.2019.11.011_bib0155","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2174\/0929866524666170110150436","article-title":"Role of AQP4\u00a0antibody serostatus and its prediction of visual outcome in neuromyelitis optica: a systematic review and metaanalysis","volume":"24","author":"Lin","year":"2017","journal-title":"Protein Pept Lett"},{"key":"10.1016\/j.jfo.2019.11.011_bib0160","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.cyto.2015.10.001","article-title":"CSF cytokines\/chemokines as biomarkers in neuroinflammatory CNS disorders: a systematic review","volume":"77","author":"Kothur","year":"2016","journal-title":"Cytokine"},{"key":"10.1016\/j.jfo.2019.11.011_bib0165","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1007\/s12035-016-9754-0","article-title":"Microarray Analysis of lncRNA and mRNA Expression Profiles in Patients with Neuromyelitis Optica","volume":"54","author":"Xu","year":"2017","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.jfo.2019.11.011_bib0085","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/bpa.12097","article-title":"Cytokines and chemokines in neuromyelitis optica: pathogenetic and therapeutic implications","volume":"24","author":"Uzawa","year":"2014","journal-title":"Brain Pathol"}],"container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S018155122030245X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S018155122030245X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:10:41Z","timestamp":1759259441000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S018155122030245X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":17,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S018155122030245X"],"URL":"https:\/\/doi.org\/10.1016\/j.jfo.2019.11.011","relation":{},"ISSN":["0181-5512"],"issn-type":[{"type":"print","value":"0181-5512"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparaison clinico-\u00e9pid\u00e9miologique des pathologies du spectre des neuromy\u00e9lites optiques","name":"articletitle","label":"Article Title"},{"value":"Journal Fran\u00e7ais d'Ophtalmologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfo.2019.11.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}